Prognostic significance of serum markers in acute exacerbation of idiopathic interstitial pneumonias

T. Arai, Y. Inoue, K. Tachibana, Y. Inoue, A. Nishiyama, C. Sugimoto, T. Kagawa, T. Okuma, M. Akira, M. Kitaichi, S. Hayashi (Sakai, Japan)

Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Session: Clinical perspectives in several interstitial diseases
Session type: Thematic Poster Session
Number: 3759
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Arai, Y. Inoue, K. Tachibana, Y. Inoue, A. Nishiyama, C. Sugimoto, T. Kagawa, T. Okuma, M. Akira, M. Kitaichi, S. Hayashi (Sakai, Japan). Prognostic significance of serum markers in acute exacerbation of idiopathic interstitial pneumonias. Eur Respir J 2011; 38: Suppl. 55, 3759

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic factors analysis of patients with acute exacerbation of idiopathic interstitial pneumonias treated by polymyxin B hemoperfusion
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013


Prognostic significance of clinical and morphological features in idiopathic interstitial pneumonias
Source: Eur Respir J 2002; 20: Suppl. 38, 61s
Year: 2002

Clinical features and predictive factors for acute exacerbation of idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis
Year: 2007


Clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Prognostic value of SVC change in fibrotic idiopathic interstitial pneumonia
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010

Prognostic significance of Glasgow Prognostic Score in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017



Clinical significance of histological classification of idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 19: 275-283
Year: 2002



Retrospective analysis of acute exacerbation in idiopathic interstitial pneumonias
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009


Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis
Source: Annual Congress 2004 - Fibrosing lung diseases
Year: 2004


Prognostic determinants in IPF patients with the histological features of usual interstitial pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 526s
Year: 2001

Clinical significance of serum CA 15-3 in patients with idiopathic interstitial pneumonias
Source: Annual Congress 2007 - Interstitial lung disease: diagnostic and therapeutic novelties
Year: 2007


Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia.
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018


Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis
Source: ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019
Year: 2020



Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 347s
Year: 2006

Eosinopenia as a prognostic factor in patients with acute exacerbation of chronic obstructive pulmonary disease.
Source: International Congress 2017 – COPD and weaning
Year: 2017

Diagnostic utility of serum KL-6 levels in acute respiratory failure with bilateral pulmonary infiltrates
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Year: 2020


Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Difference of the clinical characteristics and outcome between interstitial lung disease with dermatomyositis and idiopathic interstitial pneumonia
Source: International Congress 2017 – Lung function testing
Year: 2017

Prognostic evaluation of idiopathic interstitial pneumonia: emerging data
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010